Health News

Prostate cancer jab to be available on NHS

 10 months ago       142 Views

THE NHS is funding a revolutionary new technology proven to cut the side effects of radiotherapy for prostate cancer patients by 70 percent. The SpaceOAR hydrogel injection – supplied by manufacturer Boston Scientific – has already helped 300,000 patients and will now be rolled out to hospitals across England.

Simon Stevens, the chief executive of NHS England, said: "This further advance in NHS care for prostate cancer means patients will have safer treatment with fewer side effects. "It's another step forward in world-class cancer care." Prostate cancer is the most common cancer in men in the UK, with more than 40,000 new cases diagnosed every year. In radiotherapy high-energy X-rays are targeted at the prostate, killing cancer cells and preventing them from spreading. The SpaceOAR hydrogel, which is made mostly of water, reduces the amount of radiation that can affect nearby healthy organs.

Author: @DailyCupofYoga


Join the community!

You must be a member of healtheo360 in order to view this group

Register with Email Address

Already a member? Click here to login

healtheo360 believes strongly in user privacy.